Terms: = Germ cell tumor AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254
47 results:
1. RUNX1/npm1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma.
Cui X; Huo D; Wang Q; Wang Y; Liu X; Zhao K; You Y; Zhang J; Kang C
Cell Death Dis; 2024 Jan; 15(1):98. PubMed ID: 38286983
[TBL] [Abstract] [Full Text] [Related]
2. Novel INHAT repressor drives glioblastoma growth by promoting ribosomal DNA transcription in glioma stem cells.
Tao W; Lei H; Luo W; Huang Z; Ling P; Guo M; Wan L; Zhai K; Huang Q; Wu Q; Xu S; Zeng L; Wang X; Dong Z; Rich JN; Bao S
Neuro Oncol; 2023 Aug; 25(8):1428-1440. PubMed ID: 36521011
[TBL] [Abstract] [Full Text] [Related]
3. Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.
Pasqualetti F; Giampietro C; Montemurro N; Giannini N; Gadducci G; Orlandi P; Natali E; Chiarugi P; Gonnelli A; Cantarella M; Scatena C; Fanelli GN; Naccarato AG; Perrini P; Liberti G; Morganti R; Franzini M; Paolicchi A; Pellegrini G; Bocci G; Paiar F
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741816
[No Abstract] [Full Text] [Related]
4. Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma.
Pennington TE; Zhao CY; Colebatch AJ; Fernandez-Peñas P; Guitera P; Burke H; Scolyer RA; Menzies AM; Carlino MS; Lo S; Long GV; Saw RP
Australas J Dermatol; 2022 May; 63(2):e133-e137. PubMed ID: 35188271
[TBL] [Abstract] [Full Text] [Related]
5. Targeted Therapy in Patients with Metastatic Male germ cell tumors.
Heidenreich A; Paffenholz P; Nestler T; Tolkach Y; Pfister D
Urol Int; 2021; 105(7-8):720-723. PubMed ID: 33730730
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.
Lafita-Navarro MC; Venkateswaran N; Kilgore JA; Kanji S; Han J; Barnes S; Williams NS; Buszczak M; Burma S; Conacci-Sorrell M
PLoS Genet; 2020 Nov; 16(11):e1009117. PubMed ID: 33201894
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive Genomic Analysis of Noonan Syndrome and Acute Myeloid Leukemia in Adults: A Review and Future Directions.
Alhumaid MS; Dasouki MJ; Ahmed SO; AbalKhail H; Hagos S; Wakil S; Hashmi SK
Acta Haematol; 2020; 143(6):583-593. PubMed ID: 32541138
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
Yang F; Anekpuritanang T; Press RD
Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
[TBL] [Abstract] [Full Text] [Related]
9. Nucleolin and nucleophosmin expression in seminomas and non-seminomatous testicular tumors.
Masiuk M; Lewandowska M; Teresinski L; Dobak E; Urasinska E
Folia Histochem Cytobiol; 2019; 57(3):139-145. PubMed ID: 31513277
[TBL] [Abstract] [Full Text] [Related]
10. npm1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors.
Phi JH; Sun CH; Lee SH; Lee S; Park I; Choi SA; Park SH; Lee JY; Wang KC; Kim SK; Yun H; Park CK
BMC Cancer; 2019 Aug; 19(1):848. PubMed ID: 31462227
[TBL] [Abstract] [Full Text] [Related]
11. [Features of the Structure and Expression of npm and NCL Genes in Cutaneous Melanoma].
Ponkratova DA; Lushnikova AA
Mol Biol (Mosk); 2019; 53(4):663-673. PubMed ID: 31397440
[TBL] [Abstract] [Full Text] [Related]
12. New primary melanoma in a patient under triple therapy with vemurafenib, cobimetinib, and atezolizumab for metastatic melanoma.
Diamantopoulos PT; Lakiotaki E; Kyriakakis G; Gogas H
Melanoma Res; 2020 Apr; 30(2):206-208. PubMed ID: 31157737
[TBL] [Abstract] [Full Text] [Related]
13. Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis.
Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
Biomolecules; 2019 May; 9(5):. PubMed ID: 31137733
[TBL] [Abstract] [Full Text] [Related]
14. Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer.
Redaelli S; Ceccon M; Zappa M; Sharma GG; Mastini C; Mauri M; Nigoghossian M; Massimino L; Cordani N; Farina F; Piazza R; Gambacorti-Passerini C; Mologni L
Cancer Res; 2018 Dec; 78(24):6866-6880. PubMed ID: 30322862
[TBL] [Abstract] [Full Text] [Related]
15. Cancer stem cell markers in glioblastoma - an update.
Xu HS; Qin XL; Zong HL; He XG; Cao L
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3207-3211. PubMed ID: 28770964
[TBL] [Abstract] [Full Text] [Related]
16. MRI-detection rate and incidence of lumbar bleeding sources in 190 patients with non-aneurysmal SAH.
Kashefiolasl S; Brawanski N; Platz J; Bruder M; Senft C; Marquardt G; Seifert V; Tritt S; Konczalla J
PLoS One; 2017; 12(4):e0174734. PubMed ID: 28369075
[TBL] [Abstract] [Full Text] [Related]
17. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract] [Full Text] [Related]
18. npm1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape.
Holmberg Olausson K; Elsir T; Moazemi Goudarzi K; Nistér M; Lindström MS
Sci Rep; 2015 Nov; 5():16495. PubMed ID: 26559910
[TBL] [Abstract] [Full Text] [Related]
19. Upregulation of b23 promotes tumor cell proliferation and predicts poor prognosis in glioma.
Chen J; Sun J; Yang L; Yan Y; Shi W; Shi J; Huang Q; Chen J; Lan Q
Biochem Biophys Res Commun; 2015 Oct; 466(1):124-30. PubMed ID: 26343305
[TBL] [Abstract] [Full Text] [Related]
20. Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma.
Dolman ME; Poon E; Ebus ME; den Hartog IJ; van Noesel CJ; Jamin Y; Hallsworth A; Robinson SP; Petrie K; Sparidans RW; Kok RJ; Versteeg R; Caron HN; Chesler L; Molenaar JJ
Clin Cancer Res; 2015 Nov; 21(22):5100-9. PubMed ID: 26202950
[TBL] [Abstract] [Full Text] [Related]
[Next]
